Antimicrobial Prophylaxis
Cross-source consensus on Antimicrobial Prophylaxis from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Evidence quality
Other
Highlighted claims
- Prophylaxis is documented after therapy infusion, at last clinical follow-up, and at any infection event. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
- The study describes antibacterial, antifungal, antiviral, and anti-Pneumocystis prophylaxis strategies used in clinical care. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
- Changes in prophylactic agents over time are captured for time-dependent analyses of effectiveness. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
- For fixed-duration prophylaxis, breakthrough infections are evaluated as a marker of efficacy. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol